// App-Quantinova.ai

: Simultaneous Nail and Skin Clearance in Five Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

Researchers

Presenter

  • Boni E. Elewski

Principal Investigators

  • Andrew Blauvelt

  • Gaia Gallo

  • Eric Wolf

  • Missy McKean-Matthews

  • Russel Burge

  • Joseph F. Merola

  • Alice B. Gottlieb

  • Lyn C. Guenther

Medical Centers

  • University of Alabama at Birmingham, Birmingham, AL

  • Oregon Medical Research Center, Portland, OR

  • Eli Lilly and Company, Indianapolis, IN

  • Syneos Health, Raleigh, NC

  • Harvard Medical School, Brigham and Women's Hospital, Boston, MA.

  • Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA, Philadelphia, PA

  • The Guenther Dermatology Research Centre, London, ON, Canada

  • Western Univeristy, London, ON, Canada

Locations

  • United States

  • United Kingdom

  • Turkey

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • LY2439821

Outcome

  • N/A

Study Design

  • Active Comparator

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved